Όλο το DSpace

Πλοήγηση ανά Θέμα "neuromuscular blocking agent"

Αποτελέσματα 1-3 από 3

    • Fixed dilated pupils in Covid-19 ARDS patients under rocuronium, reversed after discontinuation 

      Zakynthinos G.E., Tsolaki V., Bardaka F., Makris D. (2021)
      Neuromuscular Blockade Agents (NMBA) are used in the management of moderate and severe Acute Respiratory Distress Syndrome (ARDS) patients. They have never been reported to present Central Nervous System adverse reactions. ...

    • Neuromuscular Blockade in the Pre- and COVID-19 ARDS Patients 

      Tsolaki V., Zakynthinos G.E., Papadonta M.-E., Bardaka F., Fotakopoulos G., Pantazopoulos I., Makris D., Zakynthinos E. (2022)
      Acute respiratory distress syndrome (ARDS) accounts for a quarter of mechanically ventilated patients, while during the pandemic, it overwhelmed the capacity of intensive care units (ICUs). Lung protective ventilation (low ...

    • Skeletal muscle relaxants in anaesthesiology 

      Benakis, A.; Plessas, C. T.; Plessas, S. T. (1999)
      During the 16th century, European explorers found that the Indians along the Amazon and Orinoco Rivers were using an arrow poison, named curare, that produced death by skeletal paralysis. Curare is one of several different ...